Henry Biggs
Adult Reconstructive Orthopaedic Surgery Naples, FL Doctor of Osteopathy
NPI 1558326538 CMS profile 25067
1250 Pine Ridge Rd, Naples, FL 34108
General payments
$49,768
Research payments
$5,000
Ownership & investment interest
$299,429
Through program year 2025, Henry Biggs of Naples, FL is reported in the CMS Open Payments database as having received $49,768 across 58 general payments and $5,000 in research payments paid to them. They also declared ownership or investment interests valued at $299,429 across 6 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 77th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
14 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $375 | 10 | |
| 2024 | General | $1,224 | 10 | |
| 2024 | Research | $5,000 | 2 | |
| 2023 | General | $247 | 5 | |
| 2022 | General | $281 | 6 | |
| 2021 | General | $2,670 | 8 | |
| 2020 | General | $1,233 | 2 | |
| 2019 | General | $43,739 | 17 | |
| 2025 | Ownership | $39,101 | 1 | |
| 2023 | Ownership | $39,101 | 1 | |
| 2022 | Ownership | $63,069 | 1 | |
| 2021 | Ownership | $56,148 | 1 | |
| 2020 | Ownership | $51,005 | 1 | |
| 2019 | Ownership | $51,005 | 1 |
Beside peers
- Henry Biggs
- Adult Reconstructive Orthopaedic Surgery median
- Middle half of Adult Reconstructive Orthopaedic Surgery
- National median
In program year 2025, general payments to Henry Biggs were reported at $375. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.
Show as a table
| Year | Henry Biggs | Adult Reconstructive Orthopaedic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $43,739 | $1,416 | $292–$9,336 | $163 |
| 2020 | $1,233 | $647 | $141–$6,474 | $114 |
| 2021 | $2,670 | $1,073 | $211–$6,497 | $132 |
| 2022 | $281 | $1,217 | $236–$6,299 | $149 |
| 2023 | $247 | $1,082 | $246–$6,818 | $160 |
| 2024 | $1,224 | $1,575 | $323–$8,944 | $164 |
| 2025 | $375 | $1,406 | $318–$8,709 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 16 drugsPart D claims
2,730
Drug cost
$26,184
Branded share of claims
15.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 339 | $7,478 | |
| Celecoxib | Generic | 328 | $6,451 | |
| Tranexamic Acid | Generic | 222 | $4,067 | |
| Ondansetron Hcl | Generic | 511 | $1,739 | |
| Zolpidem Tartrate | Generic | 544 | $1,693 | |
| Tramadol Hcl | Generic | 301 | $1,328 | |
| Cephalexin | Generic | 161 | $1,124 | |
| Diclofenac Sodium Er Diclofenac Sodium | Brand | 31 | $710 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 42 | $556 | |
| Hydromorphone Hcl | Generic | 58 | $376 |
The 10 drugs with the highest cost, of 16 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 80 billing codesPaid by Medicare
$913,831
Medicare patients
1,243
Services billed
13,982
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Arthritis | 75% | |
| High blood pressure | 71% | |
| Ischemic heart disease | 35% | |
| Depression | 22% | |
| Osteoporosis | 20% | |
| Cancer | 19% | |
| Diabetes | 17% | |
| Chronic kidney disease | 17% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg J7322 | Office | 15 | 552 | $7,548 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 112 | 652 | $505 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
60 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Adult Reconstructive Orthopaedic Surgery in Florida
Carlos Lavernia
Adult Reconstructive Orthopaedic Surgery · Miami, FL
Juan Suarez
Adult Reconstructive Orthopaedic Surgery · Miami, FL
John Redmond
Adult Reconstructive Orthopaedic Surgery · Jacksonville, FL
Gavan Duffy
Adult Reconstructive Orthopaedic Surgery · Jacksonville, FL
Timothy Van De Leur
Adult Reconstructive Orthopaedic Surgery · Summerfield, FL
Edward Stolarski
Adult Reconstructive Orthopaedic Surgery · Sarasota, FL
Related records
Adult Reconstructive Orthopaedic Surgery in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Adult Reconstructive Orthopaedic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.